Stryker Corporation provided earnings guidance for the year 2024. Based on momentum from 2023, strong procedural volumes, healthy demand for capital products and a stabilizing macro-economic environment, the company expects 2024 organic net sales growth to be in the range of 7.5% to 9.0%. Based on the steady progress of pricing actions, the company would expect the full year impact of price to be roughly flat.

If foreign exchange rates hold near current levels, the company anticipates sales will be modestly unfavorably impacted for the full year, being more negative in the first half of the year.